|
|
5-day change | 1st Jan Change | ||
|
0.6500 AUD |
-2.26% | -7.14% | -27.37% | |
Published on 03/25/2026
at 09:54 pm EDT
Reuters
This article is reserved for members Unlock the article: REGISTER NOW!
© Reuters –
2026
EBR Systems, Inc. is engaged in the treatment of patients suffering from cardiac rhythm diseases by providing physiological stimulation through endocardial pacing. It is a medical device company developing the wireless stimulation endocardially cardiac resynchronization therapy (WiSE CRT) System, an implantable cardiac pacing system that stimulates endocardial heart tissue to correct heart rhythm conditions without using leads. This investigational device delivers left-ventricle endocardial pacing for CRT without wires or leads. The WiSE CRT System developed a new approach to cardiac pacing, aiming to transform CRT delivery and benefit patients who have not succeeded with conventional CRT. It operates wholly owned subsidiaries in Australia (EBR Systems (AUST) Pty Ltd) and the United Kingdom (EBR Systems (UK) Limited), which conduct clinical trials and work on intellectual property development in their respective regions.
Trader
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Global Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Global Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
–
Global
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite), and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
–
Quality
Quality
This composite rating is the result of an average of the rankings based on the following ratings: Capital Efficiency (Composite), Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
–
ESG MSCI
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
–
Buy
Last Close Price
0.4630USD
Average target price
1.678USD
Spread / Average Target
+262.34%
Quarterly revenue – Rate of surprise
Select your edition
All financial news and data tailored to specific country editions
